# Clinical Closure — Gate 2 Prototype Disposition v1.0

## Result

**PASS — QA EVIDENCE RETAINED**

Gate 2 formally classifies the Clinical Closure v1.0 prototype and test frames as validation artifacts. They are not canonical compositions and must not be treated as additional sources of truth.

No Figma write is required for Gate 2.

## Disposition decision

The current prototype and test frames will be **retained as QA evidence** for the Phase 1 implementation.

They will not be deleted during canonicalization because they provide auditable evidence that the approved Closure Outcome vocabulary and Save/Cancel paths were exercised.

They must remain clearly named as prototype/test artifacts.

## Retained evidence

### Primary prototype states

- `333:1708` — `Clinical Closure — Phase 1 — v1.0 — Prototype — Saved`
- `333:1784` — `Clinical Closure — Phase 1 — v1.0 — Prototype — Cancelled`

### Saved outcome tests

- `334:1801` — `Clinical Closure — Phase 1 — v1.0 — Test Saved — Completed as Planned`
- `334:1884` — `Clinical Closure — Phase 1 — v1.0 — Test Saved — Completed with Modification`
- `334:1967` — `Clinical Closure — Phase 1 — v1.0 — Test Saved — Not Completed`
- `334:2050` — `Clinical Closure — Phase 1 — v1.0 — Test Saved — Treatment Continues`

### Outcome-selection tests

- `334:2216` — `Clinical Closure — Phase 1 — v1.0 — Test — Completed as Planned`
- `334:2301` — `Clinical Closure — Phase 1 — v1.0 — Test — Completed with Modification`
- `334:2386` — `Clinical Closure — Phase 1 — v1.0 — Test — Not Completed`
- `334:2471` — `Clinical Closure — Phase 1 — v1.0 — Test — Treatment Continues`

## Canonicality rule

Only one implementation may become the current canonical Clinical Closure composition.

The following are **not canonical**:

- `Clinical Closure — Phase 1 — v1.0 — Construction`
- all `Prototype` frames
- all `Test` frames
- the historical protected `220:1294` composition

The implementation candidate is currently:

`331:1366 — Clinical Closure — Phase 1 — v1.0 — Construction`

It remains temporary until Gate 3 resolves canonical naming and Gate 4 verifies the canonical implementation.

## Protected legacy rule

`220:1294 — Clinical Closure — Phase 1 — Canonical` remains:

**HISTORICAL / SUPERSEDED / PROTECTED**

Gate 2 does not authorize:

- renaming it;
- deleting it;
- modifying it;
- duplicating it;
- repurposing it;
- moving its children into another composition;
- using it as the implementation source of truth.

## Evidence integrity

The retained prototype/test frames are evidence only. They must not be used to introduce new product requirements.

If a prototype artifact exposes a behavior that conflicts with Field Specification v1.0, the specification wins unless a separate approved revision is made.

The test artifacts also do not authorize Phase 2 behavior.

## Cleanup policy

No cleanup is performed during Gate 2.

A future cleanup may remove obsolete prototype/test artifacts only if:

1. canonicalization is complete;
2. repository QA evidence has been preserved;
3. the removal is explicitly authorized;
4. the protected legacy composition remains untouched.

## Freeze boundary

Gate 2 does not freeze Clinical Closure.

The module remains:

**IMPLEMENTATION CANDIDATE / QA PASS / NOT CANONICAL / NOT FROZEN**

## Gate 2 conclusion

**PASS.**

The prototype and test frames are formally classified as retained QA evidence. They do not compete with the future canonical composition and do not alter the approved Phase 1 source of truth.

Next gate: **Gate 3 — Exact-Name Conflict Resolution.**
